name:-0.083210945129395
name:-0.050283193588257
name:-0.064306020736694
PROTHENA BIOSCIENCES LIMITED Patent Filings

PROTHENA BIOSCIENCES LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for PROTHENA BIOSCIENCES LIMITED.The latest application filed is for "antibodies recognizing tau".

Company Profile
92.89.118
  • PROTHENA BIOSCIENCES LIMITED - Dublin 2 IE
  • PROTHENA BIOSCIENCES LIMITED - Dublin IE
  • PROTHENA BIOSCIENCES LIMITED - County Dublin N/A IE
  • Prothena Biosciences Limited - Dubline IE
  • PROTHENA BIOSCIENCES LIMITED - Co. Dublin IE
  • PROTHENA BIOSCIENCES LIMITED - IE IE
  • Prothena Biosciences Limited - Dublin 1 CA IE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Antibodies Recognizing Tau
App 20220275067 - DOLAN, III; Philip James ;   et al.
2022-09-01
Methods Of Using Antibodies Recognizing Tau
App 20220267426 - Dolan, III; Philip James
2022-08-25
Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells
App 20220213223 - Comenzo; Raymond ;   et al.
2022-07-07
Humanized antibodies that recognize alpha-synuclein
Grant 11,345,749 - Saldanha , et al. May 31, 2
2022-05-31
Antibodies Recognizing Tau
App 20220153821 - NIJJAR; Tarlochan S. ;   et al.
2022-05-19
Treatment of Parkinson's Disease
App 20220098291 - PAGANO; Gennaro ;   et al.
2022-03-31
Antibodies Recognizing Tau
App 20220089702 - BARBOUR; Robin ;   et al.
2022-03-24
Anti-transthyretin antibodies
Grant 11,267,877 - Salmans , et al. March 8, 2
2022-03-08
Infrared assay detecting secondary structure profiles of alpha-synuclein
Grant 11,237,176 - Barbour February 1, 2
2022-02-01
Determination Of Parkinson's Disease
App 20220018851 - Czech; Christian ;   et al.
2022-01-20
Monitoring immunotherapy of Lewy body disease from constipation symptoms
Grant 11,191,832 - Kinney , et al. December 7, 2
2021-12-07
Anti-transthyretin Antibodies
App 20210371507 - LIU; YUE ;   et al.
2021-12-02
Antibodies Recognizing Tau
App 20210261652 - Nijjar; Tarlochan S. ;   et al.
2021-08-26
Anti-transthyretin Antibodies
App 20210188956 - Nijjar; Tarlochan S. ;   et al.
2021-06-24
Anti-transthyretin antibodies
Grant 11,028,158 - Liu , et al. June 8, 2
2021-06-08
Methods For Detecting Phosphorylated Alpha-Synuclein
App 20210165000 - Barbour; Robin ;   et al.
2021-06-03
Antibodies Recognizing Tau
App 20210130449 - Barbour; Robin ;   et al.
2021-05-06
Antibodies recognizing tau
Grant 10,961,302 - Nijjar , et al. March 30, 2
2021-03-30
Compositions for Treating Amyloidosis
App 20210079078 - KINNEY; Gene G. ;   et al.
2021-03-18
Antibody Formulations and Methods
App 20210077407 - GARIDEL; Patrick ;   et al.
2021-03-18
Dosing Regimes For Treatment Of Synucleinopathies
App 20210079103 - Soto; Jay ;   et al.
2021-03-18
Humanized Antibodies That Recognize Alpha-Synuclein
App 20210040188 - Saldanha; Jose William ;   et al.
2021-02-11
Tau Immunotherapy
App 20210032319 - SEUBERT; Peter ;   et al.
2021-02-04
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease
App 20210032318 - Schenk; Dale B. ;   et al.
2021-02-04
Antibodies recognizing tau
Grant 10,906,964 - Barbour , et al. February 2, 2
2021-02-02
Anti-transthyretin antibodies
Grant 10,906,967 - Nijjar , et al. February 2, 2
2021-02-02
Treatment and Prophylaxis of Amyloidosis
App 20210017278 - NIJJAR; Tarlochan S. ;   et al.
2021-01-21
Antibodies recognizing tau
Grant 10,889,638 - Barbour , et al. January 12, 2
2021-01-12
Anti-Laminin4 antibodies specific for LG4-5
Grant 10,889,636 - Tam , et al. January 12, 2
2021-01-12
Humanized antibodies that recognize alpha-synuclein
Grant 10,875,909 - Saldanha , et al. December 29, 2
2020-12-29
Antibodies recognizing alpha-synuclein
Grant 10,875,910 - Barbour , et al. December 29, 2
2020-12-29
Methods for detecting phosphorylated alpha-synuclein
Grant 10,852,309 - Barbour , et al. December 1, 2
2020-12-01
Antibodies Recognizing Tau
App 20200369755 - Nijjar; Tarlochan S. ;   et al.
2020-11-26
Lyophilized Formulation Of A Monoclonal Antibody Against Transthyretin
App 20200362023 - SOTO; Jay ;   et al.
2020-11-19
Anti-transthyretin Antibodies
App 20200331992 - SALMANS; Joshua Reginald ;   et al.
2020-10-22
Antibodies Recognizing Alpha-synuclein
App 20200317763 - Barbour; Robin ;   et al.
2020-10-08
Methods Of Treating Al Amyloidosis
App 20200308260 - KINNEY; Gene ;   et al.
2020-10-01
Anti-transthyretin Antibodies
App 20200277361 - Nijjar; Tarlochan S. ;   et al.
2020-09-03
Humanized Antibodies That Recognize Alpha-Synuclein
App 20200277362 - Saldanha; Jose ;   et al.
2020-09-03
Tau immunotherapy
Grant 10,752,679 - Seubert , et al. A
2020-08-25
Methods Of Detecting Transthyretin
App 20200249244 - Kind Code
2020-08-06
Humanized antibodies that recognize alpha-synuclein
Grant 10,723,792 - Saldanha , et al.
2020-07-28
Anti-MCAM Antibodies And Associated Methods Of Use
App 20200216560 - Flanagan; Kenneth ;   et al.
2020-07-09
Antibodies recognizing .alpha.-synuclein
Grant 10,669,331 - Barbour , et al.
2020-06-02
Anti-transthyretin antibodies
Grant 10,669,330 - Liu , et al.
2020-06-02
Mcam Antagonists And Methods Of Treatment
App 20200165336 - Flanagan; Kenneth ;   et al.
2020-05-28
Anti-laminin4 antibodies specific for LG4-5
Grant 10,654,920 - Tam , et al.
2020-05-19
Antibody Formulations And Methods
App 20200140534 - Garidel; Patrick ;   et al.
2020-05-07
Anti-transthyretin antibodies
Grant 10,633,433 - Nijjar , et al.
2020-04-28
Tau Immunotherapy
App 20200123239 - Seubert; Peter ;   et al.
2020-04-23
Humanized antibodies that recognize alpha-synuclein
Grant 10,597,441 - Saldanha , et al.
2020-03-24
Anti-transthyretin Antibodies
App 20200087386 - LIU; YUE ;   et al.
2020-03-19
Anti-MCAM antibodies and associated methods of use
Grant 10,584,177 - Flanagan , et al.
2020-03-10
Anti-transthyretin Antibodies
App 20200055929 - Nijjar; Tarlochan S. ;   et al.
2020-02-20
Antibodies Recognizing Medin
App 20200031914 - SHUGHRUE; PAUL JOSEPH ;   et al.
2020-01-30
Humanized Antibodies That Recognize Alpha-Synuclein
App 20200024336 - Saldanha; Jose William ;   et al.
2020-01-23
Anti-mcam Antibodies And Associated Methods Of Use
App 20200010563 - Liu; Yue
2020-01-09
Antibody formulations and methods
Grant 10,517,830 - Garidel , et al. Dec
2019-12-31
Antibody formulations and methods
Grant 10,513,555 - Garidel , et al. Dec
2019-12-24
Tau immunotherapy
Grant 10,501,531 - Seubert , et al. Dec
2019-12-10
Anti-transthyretin antibodies
Grant 10,494,426 - Nijjar , et al. De
2019-12-03
Anti-transthyretin antibodies
Grant 10,464,999 - Liu , et al. No
2019-11-05
Antibodies Recognizing Tau
App 20190330314 - Barbour; Robin ;   et al.
2019-10-31
Antibodies Recognizing Tau
App 20190330316 - BARBOUR; Robin ;   et al.
2019-10-31
Tau Immunotherapy
App 20190322728 - SEUBERT; Peter ;   et al.
2019-10-24
Humanized antibodies that recognize alpha-synuclein
Grant 10,450,369 - Saldanha , et al. Oc
2019-10-22
Antibodies Recognizing Alpha-synuclein
App 20190315843 - Barbour; Robin ;   et al.
2019-10-17
Antibodies recognizing medin
Grant 10,442,855 - Shughrue , et al. Oc
2019-10-15
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease
App 20190300598 - SCHENK; DALE B. ;   et al.
2019-10-03
Anti-MCAM antibodies and associated methods of use
Grant 10,414,825 - Flanagan , et al. Sept
2019-09-17
Infrared Assay Detecting Secondary Structure Profiles Of Alpha-synuclein
App 20190277863 - BARBOUR; Robin
2019-09-12
Anti-MCAM antibodies and associated methods of use
Grant 10,407,507 - Flanagan , et al. Sept
2019-09-10
Anti-MCAM antibodies and associated methods of use
Grant 10,407,506 - Liu Sept
2019-09-10
Assay For Detecting Total And S129 Phosphorylated Alpha-synuclein
App 20190227082 - BARBOUR; Robin ;   et al.
2019-07-25
Compositions For Treating Amyloidosis
App 20190169280 - KINNEY; GENE G. ;   et al.
2019-06-06
Antibodies recognizing alpha-synuclein
Grant 10,301,382 - Barbour , et al.
2019-05-28
Humanized Antibodies That Recognize Alpha-Synuclein
App 20190153080 - Saldanha; Jose ;   et al.
2019-05-23
Dosing Regimes For Treatment Of Synucleinopathies
App 20190153102 - Soto; Jay ;   et al.
2019-05-23
Anti-transthyretin Antibodies
App 20190071491 - Liu; Yue ;   et al.
2019-03-07
Antibodies Recognizing Alpha-synuclein
App 20190062415 - BARBOUR; ROBIN ;   et al.
2019-02-28
Anti-laminin4 Antibodies Specific For Lg4-5
App 20180371067 - Tam; Stephen Jed ;   et al.
2018-12-27
Antibodies to Alpha Synuclein
App 20180355028 - Chilcote; Tamie J. ;   et al.
2018-12-13
Humanized antibodies that recognize alpha-synuclein
Grant 10,118,960 - Saldanha , et al. November 6, 2
2018-11-06
Antibodies recognizing .alpha.-synuclein
Grant 10,081,674 - Barbour , et al. September 25, 2
2018-09-25
Anti-Laminin4 antibodies specific for LG4-5
Grant 10,059,761 - Tam , et al. August 28, 2
2018-08-28
Antibodies That Recognize Iapp
App 20180237516 - Barbour; Robin ;   et al.
2018-08-23
Anti-laminin4 Antibodies Specific For Lg4-5
App 20180208646 - Tam; Stephen Jed ;   et al.
2018-07-26
Anti-transthyretin Antibodies
App 20180201670 - Nijjar; Tarlochan S. ;   et al.
2018-07-19
Humanized Antibodies That Recognize Alpha-Synuclein
App 20180201669 - Saldanha; Jose William ;   et al.
2018-07-19
Antibodies That Recognize Iapp
App 20180171011 - Barbour; Robin ;   et al.
2018-06-21
Antibodies that recognize IAPP
Grant 9,951,131 - Barbour , et al. April 24, 2
2018-04-24
Anti-MCAM Antibodies And Associated Methods Of Use
App 20180105602 - Flanagan; Kenneth ;   et al.
2018-04-19
Humanized antibodies that recognize alpha-synuclein
Grant 9,884,906 - Saldanha , et al. February 6, 2
2018-02-06
Anti-transthyretin antibodies
Grant 9,879,080 - Nijjar , et al. January 30, 2
2018-01-30
Antibodies to alpha synuclein
Grant 9,879,071 - Chilcote , et al. January 30, 2
2018-01-30
Humanized Antibodies That Recognize Alpha-Synuclein
App 20180016329 - Saldanha; Jose ;   et al.
2018-01-18
Antibodies that recognize IAPP
Grant 9,850,302 - Barbour , et al. December 26, 2
2017-12-26
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease
App 20170349651 - Schenk; Dale B. ;   et al.
2017-12-07
Humanized Antibodies That Recognize Alpha-Synuclein
App 20170240621 - Saldanha; Jose William ;   et al.
2017-08-24
Antibodies to Alpha Synuclein
App 20170204173 - Chilcote; Tamie J. ;   et al.
2017-07-20
Methods For Detecting Phosphorylated Alpha-Synuclein
App 20170192017 - Barbour; Robin ;   et al.
2017-07-06
Anti-laminin4 Antibodies Specific For Lg1-3
App 20170158755 - Flanagan; Kenneth ;   et al.
2017-06-08
Humanized antibodies that recognize alpha-synuclein
Grant 9,670,273 - Saldanha , et al. June 6, 2
2017-06-06
Antibodies Recognizing Alpha-synuclein
App 20170152310 - BARBOUR; ROBIN ;   et al.
2017-06-01
Anti-MCAM Antibodies And Associated Methods Of Use
App 20170145109 - Flanagan; Kenneth ;   et al.
2017-05-25
Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus Arteritis
App 20170129954 - FLANAGAN; KENNETH
2017-05-11
Antibodies Recognizing Medin
App 20170121397 - Shughrue; Paul Joseph ;   et al.
2017-05-04
Anti-transthyretin Antibodies
App 20170121398 - Nijjar; Tarlochan S. ;   et al.
2017-05-04
Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus Arteritis
App 20170101470 - Liu; Yue ;   et al.
2017-04-13
Antibodies recognizing alpha-synuclein
Grant 9,605,056 - Barbour , et al. March 28, 2
2017-03-28
Anti-transthyretin Antibodies
App 20170058023 - Liu; Yue ;   et al.
2017-03-02
Anti-MCAM Antibodies And Associated Methods Of Use
App 20170037144 - Flanagan; Kenneth ;   et al.
2017-02-09
Humanized antibodies that recognize alpha-synuclein
Grant 9,556,259 - Saldanha , et al. January 31, 2
2017-01-31
Anti-transthyretin Antibodies
App 20170015737 - Nijjar; Tarlochan S. ;   et al.
2017-01-19
Anti-mcam Antibodies And Associated Methods Of Use
App 20170002089 - Liu; Yue
2017-01-05
Combination Treatment For Multiple Sclerosis
App 20170002077 - Tam; Stephen Jed ;   et al.
2017-01-05
Monitoring Immunotherapy Of Lewy Body Disease From Constipation Symptoms
App 20160279238 - Neumann; Theresa Anne ;   et al.
2016-09-29
Anti-MCAM antibodies and associated methods of use
Grant 9,447,190 - Flanagan , et al. September 20, 2
2016-09-20
Anti-transthyretin Antibodies
App 20160257736 - Nijjar; Tarlochan S. ;   et al.
2016-09-08
Anti-transthyretin Antibodies
App 20160257737 - Liu; Yue ;   et al.
2016-09-08
Antibodies Recognizing Medin
App 20160251417 - Shughrue; Paul Joseph ;   et al.
2016-09-01
Humanized Antibodies That Recognize Alpha-Synuclein
App 20160251416 - Saldanha; Jose ;   et al.
2016-09-01
Anti-transthyretin Antibodies
App 20160251418 - Liu; Yue ;   et al.
2016-09-01
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease
App 20160060331 - Schenk; Dale B. ;   et al.
2016-03-03
Tau Immunotherapy
App 20160031976 - Seubert; Peter ;   et al.
2016-02-04
Humanized antibodies that recognize alpha-synuclein
Grant 9,234,031 - Saldanha , et al. January 12, 2
2016-01-12
Humanized antibodies that recognize alpha-synuclein
Grant 9,217,030 - Saldanha , et al. December 22, 2
2015-12-22
Anti-Laminin4 Antibodies Specific for LG4-5
App 20150259408 - Tam; Stephen Jed ;   et al.
2015-09-17
Anti-MCAM Antibodies and Associated Methods of Use
App 20150259419 - Liu; Yue ;   et al.
2015-09-17
Antibodies Recognizing Alpha-synuclein
App 20150259404 - Barbour; Robin ;   et al.
2015-09-17
Treatment and delay of outset of synucleinopathic and amyloidogenic disease
Grant 9,034,337 - Schenk , et al. May 19, 2
2015-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed